[{"address1": "1200 Brickell Avenue", "address2": "Suite 1950 #1183", "city": "Miami", "state": "FL", "zip": "32183", "country": "United States", "phone": "786-432-9792", "website": "https://mirapharmaceuticals.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Erez  Aminov", "age": 45, "title": "CEO & Chairman", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 626193, "exercisedValue": 0, "unexercisedValue": 113700}, {"maxAge": 1, "name": "Ms. Michelle  Yanez M.B.A.", "age": 51, "title": "CFO, Secretary & Treasurer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 185121, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzchak  Angel Ph.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.14, "open": 1.17, "dayLow": 1.1, "dayHigh": 1.19, "regularMarketPreviousClose": 1.14, "regularMarketOpen": 1.17, "regularMarketDayLow": 1.1, "regularMarketDayHigh": 1.19, "payoutRatio": 0.0, "forwardPE": -2.3673468, "volume": 264578, "regularMarketVolume": 264578, "averageVolume": 1157020, "averageVolume10days": 867870, "averageDailyVolume10Day": 867870, "bid": 1.14, "ask": 1.2, "bidSize": 1, "askSize": 5, "marketCap": 19503892, "fiftyTwoWeekLow": 0.51, "fiftyTwoWeekHigh": 5.01, "fiftyDayAverage": 1.02056, "twoHundredDayAverage": 1.345365, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 16670908, "profitMargins": 0.0, "floatShares": 11764346, "sharesOutstanding": 16813700, "sharesShort": 493886, "sharesShortPriorMonth": 980132, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0294, "heldPercentInsiders": 0.19801001, "heldPercentInstitutions": 0.06977, "shortRatio": 2.53, "shortPercentOfFloat": 0.0381, "impliedSharesOutstanding": 16813700, "bookValue": 0.133, "priceToBook": 8.721805, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -7852659, "trailingEps": -0.51, "forwardEps": -0.49, "52WeekChange": 0.5466666, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 1.16, "targetHighPrice": 17.75, "targetLowPrice": 17.75, "targetMeanPrice": 17.75, "targetMedianPrice": 17.75, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 2832931, "totalCashPerShare": 0.168, "totalDebt": 0, "quickRatio": 3.916, "currentRatio": 3.992, "returnOnAssets": -1.2759, "returnOnEquity": -2.3889701, "freeCashflow": -2719402, "operatingCashflow": -5560606, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.7543843, "regularMarketPrice": 1.16, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1692019800000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.16, "postMarketChange": 0.0, "regularMarketChange": 0.01999998, "regularMarketDayRange": "1.1 - 1.19", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1157020, "fiftyTwoWeekLowChange": 0.65, "fiftyTwoWeekLowChangePercent": 1.2745098, "fiftyTwoWeekRange": "0.51 - 5.01", "fiftyTwoWeekHighChange": -3.8500004, "fiftyTwoWeekHighChangePercent": -0.76846313, "fiftyTwoWeekChangePercent": 54.666664, "exchange": "NCM", "messageBoardId": "finmb_1793899557", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1746228706, "regularMarketTime": 1746216001, "shortName": "MIRA Pharmaceuticals, Inc.", "longName": "MIRA Pharmaceuticals, Inc.", "epsTrailingTwelveMonths": -0.51, "epsForward": -0.49, "epsCurrentYear": -0.45, "priceEpsCurrentYear": -2.5777779, "fiftyDayAverageChange": 0.13943994, "fiftyDayAverageChangePercent": 0.1366308, "twoHundredDayAverageChange": -0.18536508, "twoHundredDayAverageChangePercent": -0.1377805, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-08-03", "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "displayName": "MIRA Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]